๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Binding of permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate

โœ Scribed by E. Carilla; M. Briley; F. Fauran; Ch. Sultan; C. Duvilliers


Book ID
116004260
Publisher
Elsevier Science
Year
1984
Tongue
English
Weight
237 KB
Volume
20
Category
Article
ISSN
0022-4731

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effects of long-term treatment withSeren
โœ Di Silverio, F.; Monti, S.; Sciarra, A.; Varasano, P.A.; Martini, C.; Lanzara, S ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 191 KB ๐Ÿ‘ 2 views

## Background: The n-hexane lipido-sterol extract of serenoa repens (lsesr, permixon, pierre fabre medicament, castres, france), a phytotherapeutic agent used in the treatment of benign prostatic hyperplasia (bph), has a multisite mechanism of action including inhibition of types 1 and 2 5alpha-red

Comparison of phytotherapy (Permixonยฎ) w
โœ Carraro, Jean-Christophe; Raynaud, Jean-Pierre; Koch, Gary; Chisholm, Geoffrey D ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 926 KB

BACKGROUND. Controversy regarding the relative efficacy of treatments for the relief of the symptoms of benign prostatic hyperplasia (BPH). METHODS. This was a 6-month double-blind randomized equivalence study that compared the effects of a plant extract (320 mg Permixon") with those of a 5a-reducta